Women and Children's Health Research Unit, Gertner Institute for Epidemiology & Health Policy Research Ltd., Tel Hashomer, Israel.
Department of Obstetrics and Gynecology, IVF Unit, Sheba Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Obes Res Clin Pract. 2019 Mar-Apr;13(2):150-155. doi: 10.1016/j.orcp.2018.11.239. Epub 2018 Nov 28.
To compare the effect of pre-pregnancy body mass index (BMI) and inappropriate gestational weight gain (GWG) on adverse obstetrical outcomes among women undergoing assisted reproductive technology (ART) treatments as compared to spontaneously-conceived (SC) pregnancies.
This prospective cohort study included 1058 pregnant women from two medical centres; 504 women who conceived following ART treatments and 554 who conceived spontaneously. The women were recruited at 8 weeks of gestation and follow-up telephone interviews were conducted 6 weeks after delivery. Obstetrical outcomes included pregnancy hypertension, gestational diabetes (GD), low birth weight (LBW) (<2500g) and small for gestational age (SGA). Multivariate analyses were used to assess the effect of pre-pregnancy BMI and inappropriate GWG on these obstetrical outcomes adjusted for risk factors.
The effect of pre-pregnancy BMI and inappropriate GWG on adverse obstetrical outcomes did not differ between ART and SC pregnancies. Pre-pregnancy obesity was found to be associated with increased risk for pregnancy hypertension (OR=2.16; 95%CI 1.16-4.03), GD (OR=2.89; 95%CI 1.61-5.17), caesarian section (OR=1.77; 95%CI 1.10-2.85) and SGA (OR=1.91; 95%CI 1.05-3.46). GWG below recommendations was associated with increased risk for GD (OR=1.73; 95%CI 1.06-2.82) and SGA (OR=1.69; 95%CI 1.17-2.40) while GWG above recommendations was associated with increased risk for pregnancy hypertension (OR=1.77; 95%CI 1.02-3.06).
Pre-pregnancy obesity and inappropriate GWG were associated with adverse obstetrical outcomes in both ART and SC pregnancies. Emphasis should be given on the importance of an optimal pre-pregnancy BMI and appropriate GWG during pregnancy.
比较孕前体重指数(BMI)和妊娠体重增加不当对接受辅助生殖技术(ART)治疗的孕妇与自然受孕(SC)孕妇不良产科结局的影响。
本前瞻性队列研究纳入了来自两家医疗中心的 1058 名孕妇;其中 504 名经 ART 治疗受孕,554 名自然受孕。这些女性在妊娠 8 周时入组,并在分娩后 6 周进行电话随访。产科结局包括妊娠高血压、妊娠期糖尿病(GD)、低出生体重(LBW)(<2500g)和小于胎龄儿(SGA)。采用多变量分析,在校正危险因素后,评估孕前 BMI 和妊娠体重增加不当对这些产科结局的影响。
ART 与 SC 妊娠中,孕前 BMI 和妊娠体重增加不当对不良产科结局的影响无差异。孕前肥胖与妊娠高血压(OR=2.16;95%CI 1.16-4.03)、GD(OR=2.89;95%CI 1.61-5.17)、剖宫产(OR=1.77;95%CI 1.10-2.85)和 SGA(OR=1.91;95%CI 1.05-3.46)的风险增加相关。低于推荐值的 GWG 与 GD(OR=1.73;95%CI 1.06-2.82)和 SGA(OR=1.69;95%CI 1.17-2.40)的风险增加相关,而高于推荐值的 GWG 与妊娠高血压(OR=1.77;95%CI 1.02-3.06)的风险增加相关。
孕前肥胖和妊娠体重增加不当与 ART 和 SC 妊娠的不良产科结局相关。应重视孕前 BMI 的最佳状态和妊娠期间适当的 GWG。